Skip to content

Clinical trials

Phase 3 Colorectal Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colorectal Neoplasms Phase: Phase 3 Country / region: Australia Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20037
20041
20051
20062
20072
20081
20091
20103
20111
20121
20134
20141
20164
20192
20203
20213
20224
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Recruiting6
Active, not recruiting5
Terminated3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche5
Pfizer5
Amgen4
Merck Sharp & Dohme LLC3
Bayer2
Bristol-Myers Squibb2
Eli Lilly and Company2
Institut de Recherches Internationales Servier2
Janssen Research & Development, LLC2
NCIC Clinical Trials Group2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colorectal Neoplasms49
Colonic Neoplasms13
Rectal Neoplasms10
Neoplasm Metastasis8
Neoplasms6
Colonic Diseases3
Digestive System Diseases3
Digestive System Neoplasms3
Gastrointestinal Diseases3
Gastrointestinal Neoplasms3

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.